José Miguel Rivera-Caravaca Selected Research

Acenocoumarol

3/2018	Antiplatelet therapy combined with acenocoumarol in relation to major bleeding, ischaemic stroke and mortality.
1/2018	Estimated absolute effects on efficacy and safety outcomes of using non-vitamin K antagonist oral anticoagulants in 'real-world' atrial fibrillation patients: A comparison with optimally acenocoumarol anticoagulated patients.
1/2018	Estimated Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants Compared With Optimally Acenocoumarol Anticoagulated "Real-World" in Patients With Atrial Fibrillation.
1/2018	A Propensity Score Matched Comparison of Clinical Outcomes in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Comparing the "Real-World" vs Clinical Trials.
1/2018	Reduced Time in Therapeutic Range and Higher Mortality in Atrial Fibrillation Patients Taking Acenocoumarol.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

José Miguel Rivera-Caravaca Research Topics

Disease

33	Atrial Fibrillation 09/2022 - 01/2017
22	Hemorrhage 01/2022 - 01/2017
17	Stroke (Strokes) 09/2022 - 07/2017
5	Ischemic Stroke 09/2022 - 03/2018
5	COVID-19 01/2022 - 01/2021
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 10/2017
3	Acute Coronary Syndrome 02/2022 - 01/2018
3	Heart Failure 01/2022 - 12/2019
2	Venous Thromboembolism 09/2022 - 01/2017
2	Thromboembolism 01/2021 - 09/2017
2	Vascular Diseases (Vascular Disease) 01/2021 - 03/2018
2	Myocardial Infarction 11/2020 - 12/2019
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 10/2020 - 01/2018
1	Mental Disorders (Mental Disorder) 03/2022
1	Diabetes Mellitus 02/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022
1	Atherosclerosis 01/2022
1	Thrombosis (Thrombus) 07/2021
1	Peripheral Arterial Disease 07/2021
1	Venous Thrombosis (Deep-Vein Thrombosis) 07/2021
1	Lung Diseases (Lung Disease) 04/2021
1	Aortic Valve Stenosis (Aortic Stenosis) 01/2021
1	Kidney Diseases (Kidney Disease) 01/2021
1	Obesity 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2021
1	Amyloid Plaque 01/2021
1	Chronic Renal Insufficiency 12/2020
1	Embolism (Embolus) 10/2020
1	Fibrosis (Cirrhosis) 01/2019
1	Fabry Disease (Fabry's Disease) 01/2019
1	Inflammation (Inflammations) 01/2019
1	Anemia 01/2019
1	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2018
1	Leukemia 10/2018
1	Splenomegaly 10/2018
1	Thrombophilia 01/2018
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2018
1	ST Elevation Myocardial Infarction 01/2018
1	Transient Ischemic Attack 07/2017
1	Pulmonary Embolism 05/2016

Drug/Important Bio-Agent (IBA)

20	Vitamin K FDA Link 09/2022 - 01/2017
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2017
11	AnticoagulantsIBA 09/2022 - 09/2017
5	AcenocoumarolIBA 03/2018 - 01/2018
4	Warfarin (Coumadin)FDA LinkGeneric 01/2021 - 01/2018
4	omega-Chloroacetophenone (Mace)IBA 11/2020 - 10/2017
3	RivaroxabanIBA 09/2022 - 01/2017
3	Factor Xa InhibitorsIBA 01/2021 - 12/2020
3	apixabanIBA 01/2018 - 01/2017
3	Dabigatran FDA Link 01/2018 - 01/2017
2	insulin receptor-related receptor (IRR)IBA 07/2022 - 04/2021
2	Amiodarone (Amiodarona)FDA LinkGeneric 01/2022 - 12/2019
2	Growth Differentiation Factor 15IBA 01/2022 - 12/2020
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2021 - 01/2018
2	MicroRNAs (MicroRNA)IBA 01/2021 - 11/2020
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2019
2	Prasugrel Hydrochloride FDA Link 01/2018 - 01/2018
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2018 - 07/2017
2	Clopidogrel (Plavix)FDA Link 01/2018 - 01/2018
2	von Willebrand FactorIBA 01/2018 - 01/2017
1	N(4)-oleylcytosine arabinosideIBA 09/2022
1	trimethyloxamine (trimethylamine N-oxide)IBA 01/2022
1	SultanIBA 01/2022
1	Digoxin (Digitek)FDA LinkGeneric 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	Particulate MatterIBA 11/2020
1	Galectin 3 (LGALS3)IBA 01/2019
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2018
1	Methotrexate (Mexate)FDA LinkGeneric 10/2018
1	Cytochrome P-450 CYP2C9IBA 06/2018
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 06/2018
1	propizepineIBA 06/2018
1	Vitamin K Epoxide ReductasesIBA 06/2018
1	Thrombin FDA Link 01/2018
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2018
1	FibrinIBA 01/2018
1	Troponin T (Troponin T1)IBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	idraparinuxIBA 01/2018
1	fibrinmonomerIBA 01/2018
1	TicagrelorIBA 01/2018
1	TroponinIBA 07/2017

Therapy/Procedure

21	Therapeutics 09/2022 - 12/2017
1	Occupational Therapy (Therapy, Occupational) 03/2022
1	Catheter Ablation 04/2021
1	Radiofrequency Ablation 04/2021
1	Bioprosthesis 01/2021
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Secondary Prevention 01/2021
1	Drug Therapy (Chemotherapy) 10/2020
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 12/2018
1	Platelet Transfusion (Blood Platelet Transfusions) 10/2018
1	Stents 01/2018
1	Percutaneous Coronary Intervention 01/2018
1	Nursing Care 05/2016